Comparing Subcutaneous Sumatriptan, intravenous Acetaminophen and intravenous Ketorolac efficacy in pain releasing for patients with acute migraine headache and the influence on patients' satisfactio
- Conditions
- Acute Migraine Headache.Migraine
- Registration Number
- IRCT20110814007327N8
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Patients aged 18-65 with a history of at least one year of migraine headache (with or without aura) with a history of 1 to 6 headache attacks of moderate to severe intensity per month in the 2 months prior to screening.
Patients with a history of congenital heart diseases.
People with cardiovascular (such as angina and other atherosclerotic diseases) and/or lung diseases.
Patients with cardiac arrhythmias even while under treatment.
Patients suffering from cerebrovascular diseases (stroke, TIA and epilepsy).
Patients suffering from ischemic bowel disease.
people having renal or hepatic failure.
Patients who have a history of alcohol or other substance abuse one year prior to the study.
Presence of any symptoms suggesting neurological defects and/or other neurological pathologies.
women who, are pregnant and/or breastfeed.
patients who use OCPs.
Patients who have asthma.
People with a known allergy to Sumatriptan and/or non-steroidal anti-inflammatory drugs.
Patients suffering from coagulopathies.
Patients having a history of basilar migraines and/or of hemiplegic migraines.
patients suffering from cluster headaches.
Patients who have a previous association with health care system, or are currently working as a health care provider (due to disturbing the blinding process.)
patients with an uncontrolled blood pressure (160 or more systole, distal 95 or more).
patients who smoke.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Satisfaction with headache control. Timepoint: hourly. Method of measurement: questionnaire.;Satisfaction with the control of accompanying symptoms. Timepoint: hourly. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method Headache control. Timepoint: hourly. Method of measurement: Visual Analog pain scale.